Australian Study Finds That Supplementation With Citrus Bioflavonoids Helps With Management Of Type 2 Diabetes

Diabetes News: Type 2 diabetes mellitus (T2DM) represents a significant global health challenge, characterized by hyperglycemia resulting from insulin resistance and impaired insulin secretion. The prevalence of T2DM has been steadily increasing, leading to a heightened focus on effective management strategies to mitigate its associated complications. These complications encompass a wide range of organ systems, including the cardiovascular, renal, neurological, and ocular systems, contributing to substantial morbidity and mortality rates worldwide.


Supplementation With Citrus Bioflavonoids Helps With Management Of Type 2 Diabetes
 
Traditionally, the management of T2DM has relied on pharmacological interventions such as metformin, sulfonylureas, glucagon-like peptide-1 receptor agonists (GLP-1RAs), and dipeptidyl peptidase-4 (DPP-4) inhibitors. However, emerging research by researchers from University of Tasmania-Australia, La Trobe University-Australia and New Medical Education Australia-Brisbane that is covered in this Diabetes News report suggests that natural compounds, particularly citrus bioflavonoids, may offer complementary therapeutic benefits in the management of T2DM and its associated complications.
 
Understanding Citrus Bioflavonoids
Citrus bioflavonoids are organic polyphenolic compounds found abundantly in citrus fruits such as oranges, lemons, and grapefruits, as well as in various vegetables. These compounds, including flavonols (e.g., quercetin, rutin), flavanones (e.g., naringin, hesperidin), and proanthocyanidins, exhibit diverse pharmacological properties, including antioxidant, anti-inflammatory, and antidiabetic activities.
 
Quercetin, a prominent flavonol, is renowned for its anti-carcinogenic, anti-inflammatory, and antidiabetic properties. Studies have demonstrated that quercetin supplementation can reduce lipid peroxidation, enhance antioxidant enzyme activity, inhibit insulin-dependent activation of PI3K, and modulate glucose absorption by blocking GLUT2 transporters.
 
Similarly, hesperidin, a flavanone found in citrus fruits, possesses anti-inflammatory, anti-hypercholesterolemic, and antioxidant effects. Animal studies have shown that hesperidin supplementation leads to reductions in total cholesterol, LDL levels, and blood glucose levels, highlighting its potential as a therapeutic agent in T2DM management.
 
Mechanisms of Action in T2DM Management
-Hyperglycemia Management: Citrus bioflavonoids exert their antihyperglycemic effects through various mechanisms. Naringin and hesperidin, for instance, inhibit starch hydrolyzing enzymes (alpha-amylase, alpha-glucosidase), reducing carbohydrate digestion and postprandial glucose levels. Additionally, these compounds can modulate glucose transporters (GLUT2, SGLT1, GLUT5), further attenuating glucose absorption in the intestine.
 
-Insulin Resistance Modulation: Flavonoids like naringenin have been shown to enhance insulin secretion from pancreatic beta c ells, improving glucose homeostasis. Furthermore, citrus bioflavonoids can enhance insulin sensitivity in insulin target tissues through pathways such as PI3K/Akt, PKA, and AMPK, crucial in glucose metabolism and cellular signaling.
 
-DPP-4 Inhibition: Recent studies have highlighted the potential of citrus bioflavonoids as DPP-4 inhibitors, a key therapeutic target in T2DM management. Compounds like hesperetin and naringenin exhibit significant inhibitory activity against DPP-4, suggesting a role in enhancing insulin synthesis and release.
 
Clinical Evidence and Therapeutic Implications
Clinical investigations and preclinical studies provide valuable insights into the therapeutic efficacy of citrus bioflavonoids in T2DM management and its related complications:
 
-Diabetic Nephropathy: Quercetin supplementation has demonstrated renoprotective effects, reducing oxidative stress, lipid peroxidation, and preserving renal function in diabetic nephropathy models. Hesperidin and naringenin have shown promise in mitigating diabetic neuropathy by reducing oxidative stress, inflammation, and enhancing nerve growth factor activity.
 
-Diabetic Retinopathy: Compounds like eriodictyol and rutin exhibit protective effects against retinal inflammation, blood-retinal barrier breakdown, and oxidative damage, offering potential therapeutic avenues in diabetic retinopathy management.
 
Furthermore, citrus bioflavonoids have been implicated in ameliorating cardiovascular risk factors associated with T2DM, including dyslipidemia, hypertension, and endothelial dysfunction. These multifaceted benefits position citrus bioflavonoids as promising adjuncts to conventional T2DM therapies, emphasizing their holistic approach to diabetes management.
 
Challenges and Future Directions
While the therapeutic potential of citrus bioflavonoids in T2DM management is promising, several challenges and avenues for future research merit consideration:
 
-Bioavailability: The bioavailability of citrus bioflavonoids, particularly in isolated forms, remains a concern, impacting their physiological efficacy and clinical translation.
 
-Standardization and Formulation: Developing standardized formulations and delivery systems to optimize bioflavonoid absorption and efficacy is crucial for their therapeutic application.
 
-Clinical Validation: Large-scale clinical trials are needed to validate the safety, efficacy, and long-term benefits of citrus bioflavonoids as adjuncts or standalone therapies in T2DM management.
 
-Combination Therapies: Exploring synergistic effects of citrus bioflavonoids with existing antidiabetic agents or lifestyle interventions could enhance treatment outcomes and patient adherence.
 
Conclusion
In conclusion, citrus bioflavonoids represent a rich source of natural compounds with diverse pharmacological properties, offering promising therapeutic avenues in T2DM management. From mitigating hyperglycemia and insulin resistance to addressing diabetic complications, these bioactive compounds exhibit multifaceted benefits that warrant further exploration and clinical validation. Incorporating citrus bioflavonoids into comprehensive diabetes care strategies holds the potential to improve outcomes and enhance the quality of life for individuals living with T2DM.
 
The study findings were published in the peer reviewed journal: Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
https://www.sciencedirect.com/science/article/pii/S1871402123001807
 
For the latest Diabetes News keep on logging to Thailand Medical News.